New Paste

Content

https://www.selleckchem.com/products/t-5224.html The Rho kinase (ROCK) inhibitor Fasudil is a promising drug for a disease-modifying therapy of amyotrophic lateral sclerosis (ALS). In preclinical models, Fasudil was shown to increase motor neuron survival, inhibit axonal degeneration, enhance axonal regeneration and modulate microglial function in vitro and in vivo. It prolonged survival and improved motor function of SOD1-G93A-mice. Recently, a phase IIa clinical trial has been commenced to investigate the safety, tolerability, and efficacy of Fasudil in ALS patients at an early stage of disease (ROCK-ALS trial, NCT03792490, Eudra-CT-Nr. 2017-003676-31). Although Fasudil has been approved in Japan for many years for the treatment of vasospasms following subarachnoid hemorrhage and is known to have a favorable side effect profile in these patients, there is no data on its use in human patients with ALS or any other neurodegenerative conditions. Here, we report the first three cases of compassionate use of Fasudil in patients with ALS. Between May 2017 and February 2019, one male (66 years old) and two female (62 and 68 years old) subjects with probable or definite ALS according to the El Escorial criteria (one of the females having a pathogenic SOD1 mutation) were administered Fasudil 30 mg intravenously twice daily over 45 min on 20 consecutive working days. Blood pressure, heart rate and routine laboratory tests were constantly controlled. All three subjects tolerated the Fasudil infusions well without any obvious side effects. Interestingly, the slow vital capacity showed a significant increase in one of the patients. Taken together, we report here the first compassionate use of the ROCK inhibitor Fasudil in three ALS patients, which was well-tolerated. Copyright © 2020 Koch, Kuttler, Maass, Lengenfeld, Zielke, Bähr and Lingor.[This corrects the article DOI 10.3389/fneur.2019.00367.]. Copyright © 2020 Groeschel, Holmström, Northam, Tournier, Baldeweg, Latal, Cafl

Optional Paste Settings

Title

Select folder or

Syntax Highlighting

Paste Expiration

Paste Status

Password

Description

Our statistics

Create and share texts quickly and easily 🚀

321,153+

Total pastes

164,609,912+

Total views

115+

Registered users

Our features

Everything you need 😉

Pastes creation

Create multiple posts quickly and easily with our powerful editor.

Folders

Store your pastes in different folders with custom names.

Paste protection

Protect your pastes with password, encryption and captcha.

Multiple syntax languages

We have 150+ syntax languages for your codes.

URL monetization

Earn money by enabling url shorteners in your pastes.

Global settings

Configure each aspect of your pastes globally.

Recent Pastes

Glashandel en glaszetter Amsterdam
HTML | 235 | 34 seconds ago
10 Misconceptions Your Boss Shares Concerning Bedside Crib Or Cot
HTML | 335 | 2 minutes ago
20 Reasons Why Gas Safety Engineer In Buckingham Will Never Be Forgott
HTML | 1K | 3 minutes ago
10 Wall Mounted Ethanol Fireplace Canada Hacks All Experts Recommend
HTML | 429 | 4 minutes ago
20 Important Questions To Ask About Best Bunk Beds For Low Ceilings Be
HTML | 574 | 5 minutes ago
A Productive Rant About CS2 Case Battles
HTML | 889 | 5 minutes ago
Why You Should Concentrate On Improving Best Bunk Beds With Storage
HTML | 0.9K | 6 minutes ago